4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-056351
Chief Operating Officer gave up 1,928 shares (to pay taxes)
- Chief Operating Officer acquired 4,947 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Williams Paul Christopher Chief Operating Officer | 2023-11-18 | Option exercise | +4,027 | 4,962 | D | ||
| Williams Paul Christopher Chief Operating Officer | 2023-11-18 | Shares withheld for taxes | −1,569 | $5.98 | $9,383 | 3,393 | D |
| Williams Paul Christopher Chief Operating Officer | 2023-11-18 | Option exercise | +920 | 4,313 | D | ||
| Williams Paul Christopher Chief Operating Officer | 2023-11-18 | Shares withheld for taxes | −359 | $5.98 | $2,147 | 3,954 | D |
| Derivatives | |||||||
| Williams Paul Christopher Chief Operating Officer | 2023-11-18 | Option exercise · Restricted Stock Units | −4,027 | 12,081 | D | ||
| Williams Paul Christopher Chief Operating Officer | 2023-11-18 | Option exercise · Restricted Stock Units | −920 | 12,273 | D | ||
Loading xslF345X05/doc4.xml…